Ian L McAllister
Overview
Explore the profile of Ian L McAllister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McAllister I, Vijayasekaran S, McLenachan S, Bhikoo R, Chen F, Zhang D, et al.
Transl Vis Sci Technol
. 2024 Jun;
13(6):13.
PMID: 38899953
Purpose: To compare gene expression changes following branch retinal vein occlusion (BRVO) in the pig with and without bevacizumab (BEV) and triamcinolone acetonide (TA). Methods: Photothrombotic BRVOs were created in...
2.
Martin E, Cook A, Frost S, Turner A, Chen F, McAllister I, et al.
Eye (Lond)
. 2024 May;
38(13):2581-2588.
PMID: 38734746
Background/objectives: Artificial intelligence can assist with ocular image analysis for screening and diagnosis, but it is not yet capable of autonomous full-spectrum screening. Hypothetically, false-positive results may have unrealized screening...
3.
McAllister I, Smithies L, Chen F, Mackey D, Sanfilippo P
Am J Ophthalmol
. 2023 Apr;
252:101-110.
PMID: 37030494
Purpose: To evaluate what clinical gains can be achieved over conventional treatment with ranibizumab alone for central retinal vein occlusion (CRVO) when causal pathology is additionally addressed successfully with a...
4.
Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide
McAllister I, Vijayasekaran S, Bhikoo R, Chen F, Zhang D, Kanagalingam E, et al.
Transl Vis Sci Technol
. 2023 Feb;
12(2):11.
PMID: 36753186
Purpose: Apoptosis is a key process in neural degeneration associated with retinal vascular diseases. Vascular endothelial growth factor (VEGF) antagonists, including bevacizumab, are used to treat macular edema in these...
5.
Eichenbaum D, Brown D, Ip M, Khanani A, Figueroa M, McAllister I, et al.
Retina
. 2023 Jan;
43(4):632-640.
PMID: 36705252
Purpose: To assess the effect of the total number of fluid-free months after loading on visual and anatomical outcomes in neovascular age-related macular degeneration patients receiving anti-vascular endothelial growth factor...
6.
Khoo Y, Yu D, Abdul-Rahman A, Balaratnasingam C, Chen F, McAllister I, et al.
Transl Vis Sci Technol
. 2023 Jan;
12(1):26.
PMID: 36692455
Purpose: The purpose of this study was to describe vessel pulse amplitude characteristics in eyes with central retinal vein occlusion (CRVO), hemiretinal vein occlusion (HVO), normal eyes (N1 N1), and...
7.
Yu D, Su E, Mehnert A, Yu P, Cringle S, Morgan W, et al.
Exp Eye Res
. 2023 Jan;
228:109386.
PMID: 36657697
We have previously reported that porcine retinal veins can be contracted by vasoactive factors such as endothelin-1, but it is still unknown which cells play the major role in such...
8.
Hunt A, Nguyen V, Bhandari S, Ponsioen T, McAllister I, Arnold J, et al.
Ophthalmol Retina
. 2022 Nov;
7(4):338-345.
PMID: 36371040
Purpose: To analyze the 3-year outcomes in a broad population of patients starting VEGF inhibitors for central retinal vein occlusion (CRVO) in routine clinical practice. Design: Observational database study. Participants:...
9.
Heath Jeffery R, Thompson J, Lo J, Lamey T, McLaren T, McAllister I, et al.
Ophthalmol Sci
. 2022 Oct;
1(1):100005.
PMID: 36246008
Purpose: To investigate atrophy expansion rate (ER) using ultra-widefield (UWF) fundus autofluorescence (FAF) in Stargardt disease (STGD1). Design: Retrospective, longitudinal study. Participants: Patients with biallelic mutations who were evaluated with...
10.
Heath Jeffery R, Thompson J, Lamey T, McLaren T, De Roach J, McAllister I, et al.
Ophthalmol Retina
. 2022 Jul;
7(1):81-91.
PMID: 35792359
Purpose: To establish disease progression rates in total lesion size (TLS), decreased autofluorescence (DAF) area, total macular volume (TMV), and mean macular sensitivity (MMS) in PRPH2-associated retinal dystrophy. Design: Single-center,...